Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Uwe Pleyer, Engi Abdel-Hady Algharably, Eugen Feist & Reinhold Kreutz. (2017) Small molecules as therapy for uveitis: a selected perspective of new and developing agents. Expert Opinion on Pharmacotherapy 18:13, pages 1311-1323.
Read now
Read now
Mark Plander & Bernadette Kalman. (2016) Rare autoimmune disorders with Mendelian inheritance. Autoimmunity 49:5, pages 285-297.
Read now
Read now
Tsai-Ching Hsu, Chun-Ching Chiu, Shun-Chih Chang, Hsu-Chin Chan, Ya-Fang Shi, Tzy-Yen Chen & Bor-Show Tzang. (2016) Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice. Virulence 7:2, pages 110-118.
Read now
Read now
Mark H. Kaplan. (2013) STAT signaling in inflammation. JAK-STAT 2:1.
Read now
Read now
Articles from other publishers (25)
Rahul Pandey, Marina Bakay & Hakon Hakonarson. (2023) SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis. Frontiers in Immunology 14.
Crossref
Crossref
Aakanksha Jha, Joseph LarkinIIIIII & Erika Moore. (2023) SOCS1‐KIR Peptide in PEDGA Hydrogels Reduces Pro‐Inflammatory Macrophage Activation. Macromolecular Bioscience.
Crossref
Crossref
Ioana S. Barac, Vitalie Văcăraș, Mihaela Iancu, Dafin F. Mureșanu & Lucia M. Procopciuc. (2023) Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate. Heliyon 9:6, pages e17427.
Crossref
Crossref
Samaneh Reiszadeh-Jahromi, Mohammad Haddadi, Pegah Mousavi & Nima Sanadgol. (2022) Prophylactic effects of cucurbitacin B in the EAE Model of multiple sclerosis by adjustment of STAT3/IL-23/IL-17 axis and improvement of neuropsychological symptoms. Metabolic Brain Disease 37:8, pages 2937-2953.
Crossref
Crossref
Caryn E. Plummer, Timothy Polk, Jatin Sharma, Sanghyo Sarah Bae, Olivia Barr, Amari Jones, Holly Kitchen, Michelle Wilhelmy, K. Devin, W. Clay Smith, Bryan D. Kolaczkowski & Joseph LarkinIIIIII. (2022) Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide. Scientific Reports 12:1.
Crossref
Crossref
Nitish Kumar, Nidhi Sharma, Rishabh Khera, Ria Gupta & Sidharth Mehan. (2021) Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain. Metabolic Brain Disease 36:5, pages 911-925.
Crossref
Crossref
Charles E. Egwuagu, Sahar A. Alhakeem & Evaristus C. Mbanefo. (2021) Uveitis: Molecular Pathogenesis and Emerging Therapies. Frontiers in Immunology 12.
Crossref
Crossref
Chun Dang, Yaoheng Lu, Xingyu Chen & Qian Li. (2021) Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway. Frontiers in Immunology 12.
Crossref
Crossref
Jatin Sharma, Teresa D. Collins, Tracoyia Roach, Shiwangi Mishra, Brandon K. Lam, Zaynab Sidi Mohamed, Antia E. Veal, Timothy B. Polk, Amari Jones, Caleb Cornaby, Mohammed I. Haider, Leilani Zeumer-Spataro, Howard M. Johnson, Laurence M. Morel & Joseph LarkinIIIIII. (2021) Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model. Scientific Reports 11:1.
Crossref
Crossref
Kailei Guo & Xiaomin Zhang. (2021) Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis. Journal of Immunology Research 2021, pages 1-19.
Crossref
Crossref
Fahad Almsned, Robert H. Lipsky & M. Saleet Jafri. (2021) Transcriptomic analysis of Multiple Sclerosis patient-derived monocytes by RNA-Sequencing for candidate gene discovery. Informatics in Medicine Unlocked 23, pages 100563.
Crossref
Crossref
Arezoo Hosseini, Zohreh Babaloo, Tohid Gharibi, Navid Shomali, Faroogh Marofi, Vida Hashemi, Hormoz Ayromlou, Milad Asadi, Shima Rahmani, Saeed Noorolyai, Dariush Shanehbandi & Behzad Baradaran. (2020) Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease. BMC Research Notes 13:1.
Crossref
Crossref
Tohid Gharibi, Zohreh Babaloo, Arezoo Hosseini, Meghdad Abdollahpour-alitappeh, Vida Hashemi, Faroogh Marofi, Kazem Nejati & Behzad Baradaran. (2020) Targeting STAT3 in cancer and autoimmune diseases. European Journal of Pharmacology 878, pages 173107.
Crossref
Crossref
Saba Manoochehrabadi, Shahram Arsang-Jang, Mehrdokht Mazdeh, Hidetoshi Inoko, Arezou Sayad & Mohammad Taheri. (2019) Analysis of STAT1, STAT2 and STAT3 mRNA expression levels in the blood of patients with multiple sclerosis. Human Antibodies 27:2, pages 91-98.
Crossref
Crossref
Julie Schallhorn. 2019. Posterior Uveitis. Posterior Uveitis
209
225
.
Peng Xia, Xiaoting Gong, Lin Xiao, Yida Wang, Tianzhuo Zhang, Qinyuan Liao, Xiaoning Mo, Xiaoyan Qiu & Jing Huang. (2018) CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Brain, Behavior, and Immunity 71, pages 158-168.
Crossref
Crossref
Suman Acharya, Maheshwor Timilshina, Liyuan Jiang, Sabita Neupane, Dong-Young Choi, Sang Won Park, Sang Yeul Lee, Byeong-Seon Jeong, Jung-Ae Kim, Tae-gyu Nam & Jae-Hoon Chang. (2018) Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation. Scientific Reports 8:1.
Crossref
Crossref
Jia-Xin Chen, Kang-Mei Huang, Meng Liu, Jin-Xiang Jiang, Jian-Peng Liu, Yu-Xiang Zhang, Chen Yang, Wen-Jun Xin & Xue-Qin Zhang. (2017) Activation of TLR4/STAT3 signaling in VTA contributes to the acquisition and maintenance of morphine-induced conditioned place preference. Behavioural Brain Research 335, pages 151-157.
Crossref
Crossref
Zhiwei You, Maheshwor Timilshina, Byeong-Seon Jeong & Jae-Hoon Chang. (2017) BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway. European Journal of Immunology 47:9, pages 1488-1500.
Crossref
Crossref
Maheshwor Timilshina, Youra Kang, Ishmit Dahal, Zhiwei You, Tae-gyu Nam, Keuk-Jun Kim, Byeong-Seon Jeong & Jae-Hoon Chang. (2017) BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression. PLOS ONE 12:1, pages e0168942.
Crossref
Crossref
Ke Ma, Xi Chen, Jia‐Cheng Chen, Ying Wang, Xi‐meng Zhang, Fan Huang, Jun‐Jiong Zheng, Xiong Chen, Wei Yu, Ke‐Ling Cheng, Yan‐Qing Feng & Huai‐yu Gu. (2016) Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses. Journal of Neurochemistry 139:6, pages 1151-1162.
Crossref
Crossref
Chang He, Cheng-Rong Yu, Mary J. Mattapallil, Lin Sun, Joseph Larkin III & Charles E. Egwuagu. (2016) SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis). Mediators of Inflammation 2016, pages 1-15.
Crossref
Crossref
John Fenimore & Howard A. Young. 2016. Regulation of Cytokine Gene Expression in Immunity and Diseases. Regulation of Cytokine Gene Expression in Immunity and Diseases
1
19
.
Ana I. RojoGethin McBeanMarina CindricJavier EgeaManuela G. LópezPatricia RadaNeven ZarkovicAntonio Cuadrado. (2014) Redox Control of Microglial Function: Molecular Mechanisms and Functional Significance. Antioxidants & Redox Signaling 21:12, pages 1766-1801.
Crossref
Crossref
Etty N. BenvenisteYudong LiuBraden C. McFarlandHongwei Qin. (2014) Involvement of the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway in Multiple Sclerosis and the Animal Model of Experimental Autoimmune Encephalomyelitis. Journal of Interferon & Cytokine Research 34:8, pages 577-588.
Crossref
Crossref